| 2026-07-29 | Press release | Perrigo to Present at the Canaccord 46th Annual Growth Conference |
| 2026-06-30 | Press release | Perrigo Announces Appointment of Two New Independent Directors to Board |
| 2026-06-08 | Press release | Perrigo Announces Leadership Transition |
| 2026-05-26 | Press release | Perrigo to Present at the Oppenheimer 26th Annual Consumer Growth & E-Commerce Conference |
| 2026-05-06 | Presentation | Presentation |
| 2026-05-06 | Press release | Perrigo Reports First Quarter 2026 Financial Results From Continuing Operations |
| 2026-04-30 | Press release | Perrigo Completes Divestiture of Dermacosmetics Business |
| 2026-04-22 | Document | Perrigo to Release First Quarter 2026 Financial Results on May 6, 2026 |
| 2026-03-03 | Press release | Perrigo to Present at the UBS Global Consumer and Retail Conference |
| 2026-02-26 | Document | Perrigo Reports Fourth Quarter and Fiscal Year 2025 Financial Results From Continuing Operations |
| 2026-02-25 | Presentation | Presentation |
| 2026-02-13 | Document | Perrigo to Release Fourth Quarter and Fiscal Year 2025 Financial Results on February 26, 2026 |
| 2025-11-18 | Press release | Perrigo to Attend Morgan Stanley Global Consumer & Retail Conference |
| 2025-11-05 | Document | Perrigo Reports Third Quarter 2025 Financial Results From Continuing Operations |
| 2025-11-04 | Presentation | Presentation |
| 2025-11-05 | Press release | Perrigo to Conduct Strategic Review of its Infant Formula Business |
| 2025-11-04 | Press release | Perrigo to Attend Jefferies Consumer Conference |
| 2025-10-22 | Document | Perrigo to Release Third Quarter 2025 Financial Results on November 5, 2025 |
| 2025-08-20 | Press release | Perrigo to Attend Barclays 18th Annual Global Consumer Staples Conference |
| 2025-08-06 | Document | Perrigo Reports Second Quarter 2025 Financial Results From Continuing Operations |
| 2025-07-29 | Press release | Perrigo to Present at the Canaccord Genuity 45th Annual Growth Conference |
| 2025-07-23 | Document | Perrigo to Release Second Quarter 2025 Financial Results on August 6, 2025 |
| 2025-07-14 | Press release | Perrigo Announces Agreement to Divest Dermacosmetics Business for up to €327 Million |
| 2025-07-01 | Press release | Perrigo Announces Strategic Organizational Update to Drive Sustainable Growth and Performance |
| 2025-06-04 | Press release | Perrigo Announces Global Operations and Supply Chain Leadership Transition |
| 2025-05-23 | Press release | Perrigo to Attend the Oppenheimer 25th Annual Consumer Growth & E-Commerce Conference |
| 2025-05-07 | Document | Perrigo Reports First Quarter 2025 Financial Results From Continuing Operations |
| 2025-05-07 | Presentation | Presentation |
| 2025-04-23 | Document | Perrigo to Release First Quarter 2025 Financial Results on May 7, 2025 |
| 2025-02-28 | Press release | Perrigo Provides Detailed Plan to Consumerize, Simplify and Scale its Unique Global Self-Care Platform at its Virtual In |
| 2025-02-26 | Press release | Perrigo to Attend the UBS 2025 Global Consumer and Retail Conference |
| 2025-01-31 | Press release | Perrigo to Release Fourth Quarter and Fiscal Year 2024 Financial Results on February 27, 2025, Host Virtual Investor Day |
| 2025-01-06 | Press release | Perrigo Expands its Scientific Office; Appoints Abbie Lennox as Executive Vice President and Chief Scientific Officer |
| 2024-09-26 | Press release | Perrigo Announces Good Start® and Dr. Browns® Brand Partnership and Launch of Infant Formula Portfolio |
| 2024-09-17 | Press release | PERRIGO ANNOUNCES THE CLOSING OF A SENIOR NOTES OFFERING BY ITS FINANCE SUBSIDIARY, PERRIGO FINANCE UNLIMITED COMPANY |
| 2024-09-12 | Press release | PERRIGO ANNOUNCES THE PRICING OF A SENIOR NOTES OFFERING BY ITS FINANCE SUBSIDIARY, PERRIGO FINANCE UNLIMITED COMPANY |
| 2024-09-04 | Press release | Perrigo Appoints Industry Veteran, Charles Atkinson, as Executive Vice President, General Counsel and Secretary |
| 2024-08-27 | Press release | Perrigo to Attend the Piper Sandler Growth Frontiers Conference |
| 2024-08-19 | Press release | Perrigo Appoints David Ball to the Newly Created Position of Executive Vice President and Chief Brand and Digital Office |
| 2024-07-10 | Press release | Perrigo Completes Divestment of HRA Pharma Rare Diseases Business |